goralatide has been researched along with Lupus Nephritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carretero, OA; D'Ambrosio, M; Janic, B; Liao, TD; Nakagawa, P; Peterson, EL; Rhaleb, NE; Worou, ME; Yang, XP | 1 |
| Huang, B; Liang, Y; Tan, H; Wang, H; Wang, S; Yang, N; Yu, X; Zhang, L; Zhao, J | 1 |
2 other study(ies) available for goralatide and Lupus Nephritis
| Article | Year |
|---|---|
N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.
Topics: Animals; Cell Movement; Complement System Proteins; Cytokines; Disease Models, Animal; Female; Glomerular Filtration Rate; Intercellular Adhesion Molecule-1; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; Oligopeptides; T-Lymphocytes | 2015 |
Ac-SDKP ameliorates the progression of lupus nephritis in MRL/lpr mice.
Topics: Actins; Animals; Antibodies, Antinuclear; Body Weight; Chemokine CCL2; Drug Administration Schedule; Female; Fibronectins; Gene Expression Regulation; Inflammation; Kidney; Leukocytes; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; NF-kappa B; Oligopeptides; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2012 |